Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
Hur MH, Cho Y, Kim DY, Lee JS, Kim GM, Kim HC, Sinn DH, Hyun D, Lee HA, Seo YS, Lee IJ, Park JW, Kim YJ.
Hur MH, et al. Among authors: lee js, lee ha, lee ij.
Clin Mol Hepatol. 2023 Jul;29(3):763-778. doi: 10.3350/cmh.2023.0076. Epub 2023 May 30.
Clin Mol Hepatol. 2023.
PMID: 37254488
Free PMC article.